VHTvsXLVIETF Comparison
VS
ETF 2
XLVI
State Street Health Care Select Sector SPDR Premium Income Fund
This fund is part of
Options Strategies
-0.25%
Vanguard Health Care ETF (VHT) belongs to the US Health Care segment. State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) is part of the Options Strategies segment. VHT's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, XLVI's top sector exposures are Healthcare and Consumer Non-Cyclicals. VHT is less expensive with a Total Expense Ratio (TER) of 0.09%, versus 0.35% for XLVI. VHT is up 9.64% year-to-date (YTD) with +$105M in YTD flows. XLVI performs worse with 6.27% YTD performance, and +$14M in YTD flows. Run a side-by-side ETF comparison of VHT and XLVI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
VHT vs XLVI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/09/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | VHT XLVI | -1.13%-3.23% | +9.33%+4.05% | +9.64%+6.27% | +23.40%+16.84% | +34.65%n/a | +29.09%n/a |
| Flows | VHT XLVI | +$89M+$4M | +$388M+$11M | +$105M+$14M | +$333M+$25M | -$2.16B- | -$956M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | VHT XLVI | +18.32%+11.85% | +15.77%+11.08% | +14.66%n/a | +15.57%n/a |
| Max drawdown | VHT XLVI | -4.91%-4.26% | -10.39%-8.21% | -16.88%n/a | -17.77%n/a |
| Max drawdown duration | VHT XLVI | 21d15d | 169d115d | 435dn/a | 767dn/a |
Trading data
VHT | XLVI | |
Last sale 9/10/2026 at 5:15 PM | $311.82 | $25.78 |
| Previous close 09/09/2026 | $313.30 | $25.87 |
| Consolidated volume 09/09/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XLVI
is actively managed and doesn’t replicate an indexVHT | XLVI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/10/2026 at 5:15 PM
Live
Closed
VHT | XLVI | |
|---|---|---|
| Last price | $311.82 | $25.78 |
| 1D performance | -0.47% | -0.35% |
| AuM | $18.95 B | $25.61 M |
| E/R | 0.09% | 0.35% |
Characteristics
VHT | XLVI | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Vanguard | State Street Investment Management |
| Benchmark | MSCI US IMI Health Care 25/50 Index | - |
| N° of holdings | 413 | 59 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 26, 2004 | July 30, 2025 |
| ESG | No | No |
Advertisement
Exposure
Countries
VHT
USA
96.91%
Other
3.09%
XLVI
USA
97.34%
Other
2.66%
Sectors
VHT
Healthcare
97.52%
Other
2.48%
XLVI
Healthcare
97.32%
Other
2.68%
Advertisement
Diversification
VHT
Total weight of top 15 holdings out of 15
61.16%
XLVI
Total weight of top 15 holdings out of 15
71.63%
Top 15 holdings
Data as of July 31, 2026
VHT
Eli Lilly & Co.
13.37%
Johnson & Johnson
8.83%
AbbVie, Inc.
6.43%
UnitedHealth Group, Inc.
5.45%
Merck & Co., Inc.
4.67%
Thermo Fisher Scientific, Inc.
3.09%
Amgen, Inc.
3.01%
Abbott Laboratories
2.67%
Gilead Sciences, Inc.
2.34%
Pfizer Inc.
2.06%
Bristol Myers Squibb Co.
1.93%
CVS Health Corp.
1.93%
Intuitive Surgical, Inc.
1.82%
Danaher Corp.
1.80%
Vertex Pharmaceuticals, Inc.
1.76%
XLVI
Eli Lilly & Co.
15.45%
Johnson & Johnson
10.49%
AbbVie, Inc.
7.54%
UnitedHealth Group, Inc.
6.40%
Merck & Co., Inc.
5.47%
Thermo Fisher Scientific, Inc.
3.63%
Amgen, Inc.
3.53%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.42%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
Frequently asked questions about VHT and XLVI
How have the VHT and XLVI ETFs performed in 2026?
As of September 9, 2026, VHT is up 9.64% year-to-date (YTD), while XLVI has returned 6.27%. That puts VHT better performer ahead so far this year.
Which ETF is attracting more investor money: VHT or XLVI?
Year-to-date, the VHT ETF saw +$105M in flows, compared to +$14M for XLVI.
Which ETF is more volatile: VHT or XLVI?
Over the past year, VHT had a volatility of 15.77%, while XLVI experienced 11.08%.
Which ETF is bigger: VHT or XLVI?
As of September 9, 2026, VHT holds $18.95 B in assets under management (AUM), while XLVI manages $25.61 M.
What sectors do the VHT and XLVI ETFs invest in?
VHT leans toward sectors like Healthcare. Meanwhile, XLVI focuses on Healthcare.
What are the top holdings of the VHT ETF and XLVI ETF?
VHT top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. XLVI holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: VHT or XLVI?
VHT holds 413 securities with 61.16% of its assets in the top 15. XLVI has 59 securities and a top 15 weight of 71.63%.
Advertisement
Latest news about VHT & XLVI
My Contrarian Equity ETF Picks For 2026
November 13, 2025
VHT
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
VHT
Health Care Sector Down After a Cyberattack on UnitedHealth
March 4, 2024
VHT
Advertisement
2024 Stock Market Predictions from Vanguard, BlackRock, & State Street: ETFs to Watch
January 5, 2024
VHT
Tony's ETF Buyer's Guide: Sector ETFs (Vanguard versus State Street SPDR)
December 1, 2023
VHT
Defensive investing: Utility and healthcare sector ETFs
November 30, 2022
VHT
Advertisement
